Last updated on February 2019

A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma


Brief description of study

The primary objective of this study is to evaluate the tolerability and safety of a combination of lenvatinib plus nivolumab in participants with hepatocellular carcinoma (HCC).

Clinical Study Identifier: NCT03418922

Contact Investigators or Research Sites near you

Start Over

Customer Joy Department. EJ

Eisai Trial Site 4
Osakasayama, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.